| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.43 | 1e-15 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 6e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |